Page last updated: 2024-11-07

gadolinium sulfoxylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gadolinium sulfoxylate: used in radiation-protective screen; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159444
MeSH IDM0075759

Synonyms (11)

Synonym
68609-43-8
gadolinium sulfur oxide
digadolinium dioxide sulphide
gadolinium sulfoxylate
einecs 235-598-4
europium doped gadolinium oxysulfide nanopowder
gadolinium oxide sulfide (4/3/3)
DTXSID70910021
106496-57-5
gadolinium(3+);oxygen(2-);trisulfide
gadolinium oxysulfide, terbium-doped

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The present system allows a significant reduction in radiation dosage with maintenance of fine to excellent radiographic resolution."( Low-dose radiography of children.
Blumhagen, JD; Gilbert, JM; Hilton, SV; Nedeau, DJ; Rossi, RP; Wesenberg, RL,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (5.88)18.7374
1990's5 (14.71)18.2507
2000's11 (32.35)29.6817
2010's14 (41.18)24.3611
2020's2 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.32 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (97.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]